It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Identify index funds with the lowest tax drag by examining turnover, fund composition, and distributions to optimize after-tax retirement growth.
27,308 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
AI demand is driving a surge in data-center energy use, and space won’t be a quick fix. This report explains why runn...
Gold is leading gains in early 2026, while silver remains volatile. Analysts say the evolving ETF landscape is paving...
Hewlett Packard Enterprise beats expectations, pulling forward its 2028 targets by two years as AI infrastructure dem...
Wall Street chatter about a SpaceX and Tesla merger has sparked a wave of questions. This article unpacks what the ph...
The Commerce Department reports 2025 trade data showing a modest narrowing of the U.S. deficit to about $901 billion,...
Broadcom reports AI-related revenue more than doubles in the latest quarter, but the stock trades flat as investors w...
Rumors about celebrity romance grab headlines and budgets alike. This guide breaks down the financial impact of publi...
Anthropic’s rumored trillion-dollar IPO has investors buzzing, yet a wave of caution surrounds the offering amid valu...
A bold take on Tesla's future: could the Optimus robot redefine the company and its stock by 2026? This article lays ...
Netflix shares jumped after price hikes, signaling pricing power in streaming. This in-depth look explains what happe...
Coinbase stock trades around the mid-180s as crypto markets swing. Analysts offer a wide range of year-end targets, h...